Heart failure incidence was 1.65 events per 1000 person-years in people with HIV, with higher incidence seen in women and those with hypertension or obesity.
What is the incidence of heart failure events, and does the PREVENT HF risk score accurately predict these events in people with HIV at low-to-moderate ASCVD risk?
The PREVENT HF risk score accurately predicts heart failure events in a global population of people with HIV at low-to-moderate cardiovascular risk.
Absolute Event Rate: 0% vs 0%
BACKGROUND: People with HIV (PWH) may have a higher risk of heart failure (HF) due to traditional and HIV-related factors. Incidence and risk prediction of HF in PWH are not well characterized. We aimed to quantify the risk of HF events in a global population of PWH with low-to-moderate estimated atherosclerotic cardiovascular disease risk. METHODS: HF incidence (events/1000 person years) was described overall and by demographic, HIV-specific, and HF factors, including estimated Predicting Risk of Cardiovascular Disease Events 10-year risk of HF. Confirmed HF events included adjudicated HF hospitalization and adverse events identified via a standardized Medical Dictionary for Regulatory Archives HF query. RESULTS: We analyzed 7769 REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV) participants from 5 global regions (median, 50 years; 31% female). Over a median follow-up of 5.6 years (interquartile range, 4.3–5.9), HF incidence was higher in women, among Black participants in high-income regions, participants in sub-Saharan Africa, and among those with preexisting hypertension and obesity compared with the absence of these factors. Current and nadir CD4+T-cell count, and HIV-1 RNA level were not related to the incidence of HF events. Median (Q1–Q3) Predicting Risk of Cardiovascular Disease Events HF score was 1.66% (1.01–2.62). HF incidence was 1.65/1000 person-years (95% CI, 1.30–2.09). Expected number of HF events by Predicting Risk of Cardiovascular Disease Events HF (n=73) was consistent with observed (n=67). CONCLUSIONS: Select demographics, clinical factors, and global regions contribute to a higher incidence of HF events among PWH. In PWH, the observed overall number of HF events aligned with the estimated Predicting Risk of Cardiovascular Disease Events HF risk rates.
Bloomfield et al. (Mon,) reported a other. Heart failure incidence was 1.65 events per 1000 person-years in people with HIV, with higher incidence seen in women and those with hypertension or obesity.